Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 18:39:17 15/07/2024 BST			5-day change	1st Jan Change
0.075 ^CAD	-25.00%		0.00%	-25.00%

07-04	Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024	CI
04-29	Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024	CI

MPV Exploration Inc. has filed an IPO in the amount of CAD 1 million.

January 04, 2018 at 05:00 am

MPV Exploration Inc. has filed an IPO in the amount of CAD 1 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 5,000,000 PriceRange: CAD 0.2 Discount Per Security: CAD 0.02

Latest news about Entheon Biomedical Corp.

Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024	07-04	CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024	04-29	CI
Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding	04-17	CI
Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding	04-10	CI
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023	03-26	CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	26/10/23	CI
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer	01/08/23	CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	26/07/23	CI
Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors	28/06/23	CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023	28/04/23	CI
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin	28/04/23	CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt	22/03/23	CI
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director	02/03/23	CI
Entheon Biomedical Corp. Announces CFO Changes	05/01/23	CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	31/10/22	CI
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101	05/10/22	CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	26/07/22	CI
Entheon Biomedical Corp. cancelled the transaction announced on April 5, 2022	06/06/22	CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2022	29/04/22	CI
Entheon Biomedical Corp. announced that it expects to receive CAD 3 million in funding	04/04/22	CI
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2021	30/03/22	CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt	29/03/22	CI
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel, New Clinical Research Platform	29/03/22	MT
Entheon Biomedical Corp. Announces Enrollment in Phase 1 Study of DMT	15/03/22	CI
Entheon Biomedical Corp. Announces EBIQ-101 First-Patient Dose	24/02/22	CI

Chart Entheon Biomedical Corp.

Duration

Period

More charts

Company Profile

Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is focused on treating addiction and substance-use disorders.

Sector

Biotechnology & Medical Research

Calendar

23/10/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ENTHEON BIOMEDICAL CORP.	-25.00%	485K
MODERNA, INC.	+25.83%	47.96B
IQVIA HOLDINGS INC.	+0.69%	42.45B
LONZA GROUP AG	+44.08%	41.47B
ALNYLAM PHARMACEUTICALS, INC.	+30.52%	31.6B
ICON PUBLIC LIMITED COMPANY	+22.30%	28.63B
CELLTRION, INC.	-6.35%	28.03B
UNITED THERAPEUTICS CORPORATION	+49.25%	14.56B
MEDPACE HOLDINGS, INC.	+49.18%	14.14B
BIO-TECHNE CORPORATION	+3.45%	12.58B

Other Biotechnology & Medical Research